Precision Biosciences gets grant for engineered meganucleases for modifying human mitochondrial dna
Pharmaceutical Technology
APRIL 30, 2024
Discover how this mitochondria-targeting engineered meganuclease is revolutionizing genetic research. Unlock the potential of genetic modification with Precision Biosciences Inc's patented MTEM technology for precise editing of eukaryotic cells.
Let's personalize your content